ZKSCAN1 and prediabetes syndrome: In conclusion, our present results show that mild prediabetes induces miRNA expression changes leading to altered gene expression of Jazf1, Zkscan1, and Rap2c, which may contribute to the diastolic dysfunction and may serve as potential drug targets.